GlaxoSmithKline have scored another Victory...
Today the US FDA voted to allow GSK's money-making diabetic drug Avandia to remain on the market. However, not everyone on the FDA review panel agreed.
Today the US FDA voted to allow GSK's money-making diabetic drug Avandia to remain on the market. However, not everyone on the FDA review panel agreed.
In fact, out of the 33 panel members, 12 of them wanted to withdraw it, and 10 wanted it to remain on the market with serious revisions to the label. Other than one other member abstaining, the rest were happy to continue 'business as is'.
Hmm...I bet there was a bit of lobbying going on before the vote was made! Is this drug really necessary? Obviously there are widely different opinions about this. One thing that I can safely say is that it should only be a drug of last resort, when the basics (which usually work) have failed...such as diet and exercise.
Unfortunately, Avandia - like so many drugs - is prescribed as the first line of action by many doctors rather than them spending the time to help educate their patients about lifestyle changes to eliminate the cause of the disease and avoid the drug dependency.
You can find out more by reading this article...
You may also like...
General Health
Top 10 Impacts of Malnutrition
January 2020 by, Jessica Bell
The modern lifestyle of stress, processed foods and environmental pollutants means you could be lacking the nutrients needed...
Read More
General Health
Fish Oil – How Fresh Is Yours?
July 2019 by, Xtend-Life Expert
You probably know that omega 3 is really good for long term health, but did you know how...
Read More
General Health
Carin's Story: When Lifestyle Isn't Enough
March 2019 by, Customer Care Team
Carin is a long term customer and holistic practitioner, she knew the path to true wellness wouldn't happen overnight...
Read More
Leave a Comment